跳至主要内容
临床试验/NCT03561064
NCT03561064已完成不适用

Improving Sleep in Cancer Patients: A Feasibility Trial of Implementing Cognitive Behavioral Therapy for Insomnia During Cancer Treatments

Dartmouth-Hitchcock Medical Center2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年4月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Change of the score on the Insomnia Severity Index (ISI)

研究概览

简要总结

The purpose of this study is to determine if CBT-I (cognitive behavioral therapy for insomnia) is a feasible treatment for insomnia in individuals undergoing cancer treatment.

详细描述

This research study is a single arm feasibility trial in which all eligible participants receive five weekly sessions of CBT-I (cognitive behavioral therapy for insomnia) delivered before or during their cancer treatments. CBT-I is a non-drug behavioral treatment for insomnia and is considered the most effective treatment for insomnia. However, CBT-I is not routinely offered to cancer patients due to unknowns about its feasibility in this population. Data will be obtained at pre- and post-CBT-I and at eight-week follow-up, and will focus on acceptability, implementation, and efficacy in order to assess feasibility. The study will focus on cancer patients who are diagnosed with gastro-intestinal (GI) cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18+ years of age
  • have insomnia disorder (SOL or WASO greater than 30 minutes for more than 6 nights in two weeks + daytime impairments)
  • are diagnosed with gastro-intestinal cancer;
  • have life expectancy > 6 months;
  • are fully ambulatory indicated by the provider-rated score of greater than 2 on the Eastern Cooperative Oncology Group (ECOG) performance measure;
  • will complete cancer treatments in no less than seven weeks, allowing for two weeks of assessments and five weeks of CBT-I;
  • are English-speaking and able to provide voluntary, written consent.

排除标准

  • unmanaged sleep apnea indicated by the scores on the STOP-BANG Questionnaire suggesting high risk for sleep apnea and not receiving any sleep apnea treatment;
  • other sleep disorders;
  • bipolar disorder;
  • unmanaged serious mental illnesses;
  • suicidal ideation/intent/plan;
  • unstabilized pharmacological treatment for insomnia;
  • night-shift employment.

研究组 & 干预措施

Receiving CBT-I

Experimental

This is a single arm study. All participants will receive CBT-I (cognitive behavioral therapy for insomnia).

干预措施: CBT-I (Behavioral)

结局指标

主要结局

Change of the score on the Insomnia Severity Index (ISI)

时间窗: baseline and at 19th week

The ISI assesses the severity of insomnia symptoms and subjective daytime impairments.

次要结局

  • Change of diary-assessed sleep onset latency(baseline and at 19th week)
  • Change of actigraphy-sleep onset latency(baseline and at 19th week)
  • Change of actigraphy-assessed wake after sleep onset(baseline and at 19th week)
  • Change of diary-assessed wake after sleep onset(baseline and at 19th week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sivan Rotenberg

Assistant Professor

Dartmouth-Hitchcock Medical Center

研究点 (2)

Loading locations...

相似试验